Article Information
- Received October 21, 2014
- Revision received February 18, 2015
- Accepted February 23, 2015
- First published April 29, 2015.
- Version of record published April 29, 2015.
Author Information
- Gemma Navarro1,*,
- César Quiroz2,*,
- David Moreno-Delgado1,*,
- Adam Sierakowiak2,
- Kimberly McDowell2,
- Estefanía Moreno1,
- William Rea2,
- Ning-Sheng Cai2,
- David Aguinaga1,
- Lesley A. Howell3,
- Felix Hausch4,
- Antonio Cortés1,
- Josefa Mallol1,
- Vicent Casadó1,
- Carme Lluís1,
- Enric I. Canela1,†,
- Sergi Ferré2,†, and
- Peter J. McCormick1,3,†
- 1Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Center for Biomedical Research in Neurodegenerative Diseases Network and Institute of Biomedicine of the University of Barcelona, 08028 Barcelona, Spain,
- 2Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224,
- 3School of Pharmacy, University of East Anglia, Norwich, NR4 7TJ, United Kingdom, and
- 4Max Planck Institute of Psychiatry, 80804 Munich, Germany
Author contributions
Author contributions: G.N., D.M.-D., C.Q., W.R., N.-S.C., D.A., L.A.H., F.H., A.C., J.M., V.C., C.L., E.I.C., S.F., and P.J.M. designed research; G.N., D.M.-D., C.Q., A.S., K.M., W.P.R., E.M., and P.J.M. performed research; G.N., D.M.-D., C.Q., W.R., E.M., C.L., S.F., and P.J.M. analyzed data; G.N., D.M.-D., C.Q., C.L., S.F., and P.J.M. wrote the paper.
↵*G.N., C.Q., and D.M.D. contributed equally to this manuscript.
Disclosures
- Received October 21, 2014.
- Revision received February 18, 2015.
- Accepted February 23, 2015.
↵†E.I.C., S.F., and P.J.M. are senior co-authors.
This work was supported by intramural funds of the National Institute on Drug Abuse, from Spanish Ministry of Science and Technology Grants SAF2011-23813 and SAF2009-07276, Government of Catalonia Grant 2009-SGR-12, and Center for Biomedical Research in Neurodegenerative Diseases Network Grant CB06/05/0064. P.J.M. was supported through a Ramón y Cajal Fellowship. We thank Jasmina Jiménez for technical assistance.
The authors declare no competing financial interests.
- Correspondence should be addressed to either of the following: Dr. Sergi Ferré, Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, Triad Technology Building, 333 Cassell Drive, Baltimore, MD 21224, sferre{at}intra.nida.nih.gov; or Dr. Peter J. McCormick, School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK. p.mccormick{at}uea.ac.uk
Online Impact
Article usage
In this issue
